GlassScriptPhysician profile
Kyle Tedd Kunz
NPI 1215457429
$650.59
in general payments reported to CMS, 2019-2025
14 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $65.52 · 2023: $106 · 2024: $79.00 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $159.87 | 2021-2023 | |
| Novo Nordisk INC | $111.56 | 2021 | |
| Becton, Dickinson and Company | $79.00 | 2024 | |
| Antares Pharma, INC. | $61.44 | 2025 | Xyosted |
| Exact Sciences Corporation | $42.97 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $36.33 | 2023 | Mounjaro, Emgality, Jardiance |
| Amgen INC. | $31.47 | 2025 | Repatha |
| Dexcom, INC. | $27.35 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $19.36 | 2022 | |
| Baxter Healthcare | $18.65 | 2025 | Biopharma Sol - Contract Manuf |
| Viiv Healthcare Company | $18.11 | 2025 | Apretude |
| Esperion Therapeutics, INC. | $15.28 | 2025 | Nexletol |
| Phathom Pharmaceuticals, INC. | $15.21 | 2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kunz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.